Abstract:Background & Aims: Either activation of mTORC1 due to loss of Tsc1 (tuberous sclerosis complex 1) or defective hepatic autophagy due to loss of Atg5 leads to spontaneous liver tumorigenesis in mice. The purpose of this study was to investigate the mechanisms by which autophagy contributes to the hepatic metabolic changes and tumorigenesis mediated by mTORC1 activation. Methods: Atg5 Flox/Flox (Atg5(F/F)) and Tsc1(F/F) mice were crossed with albumin-Cre mice to generate liver-specific Atg5 knockout (L-Atg5 KO), L-Tsc1 KO and L-Atg5/Tsc1 double KO (DKO) mice. These mice were crossed with p62/Sqstm1(F/F) (p62) and whole body Nrf2 KO mice to generate L-Atg5/Tsc1/p62 and L-Atg5/Tsc1-Nrf2 triple KO mice. These mice were housed for various periods up to 12 months, and blood and liver tissues were harvested for biochemical and histological analysis Results: Deletion of Atg5 in L-Tsc1 KO mice inhibited liver tumorigenesis but increased mortality and was accompanied by drastically enhanced hepatic ductular reaction (DR), hepatocyte degeneration and metabolic reprogramming. Deletion of p62 reversed DR, hepatocyte degeneration and metabolic reprogramming as well as the mortality of L-Atg5/Tsc1 DKO mice, but unexpectedly promoted liver tumorigenesis via activation of a group of oncogenic signaling pathways. Nrf2 ablation markedly improved DR with increased hepatocyte population and improved metabolic reprogramming and survival of the L-Atg5/Tsc1 DKO mice without tumor formation. Decreased p62 and increased mTOR activity were also observed in a subset of human hepatocellular carcinomas. Conclusions: These results reveal previously undescribed functions of hepatic p62 in suppressing tumorigenesis and regulating liver cell repopulation and metabolic reprogramming resulting from persistent mTORC1 activation and defective autophagy. Lay summary: Metabolic liver disease and viral hepatitis are common chronic liver diseases and risk factors of hepatocellular carcinoma, which are often associated with impaired hepatic autophagy and increased mTOR activation. Using multiple genetically engineered mouse models of defective hepatic autophagy and persistent mTOR activation, we dissected the complex mechanisms behind this observation. Our results uncovered an unexpected novel tumor suppressor function of p62/Sqstm1, which regulated liver cell repopulation, ductular reaction and metabolic reprogramming in liver tumorigenesis. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Regulation Of Cell Proliferation And Migration By P62 Through Stabilization Of Twist1 In Human Scc And Melanoma Cells

Autophagy Regulates Tumor Growth and Metastasis

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA

Overexpression of P62/imp2 Can Promote Cell Migration in Hepatocellular Carcinoma Via Activation of the Wnt/β-Catenin Pathway

Autophagic Regulation of P62 is Critical for Cancer Therapy

An Unexpected Tumor Suppressor Role of SQSTM1/p62 in Liver Tumorigenesis

P62 Promotes Proliferation, Apoptosis‑resistance and Invasion of Prostate Cancer Cells Through the Keap1/Nrf2/ARE Axis

SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration

p62 Promotes Malignancy of Hepatocellular Carcinoma by Regulating the Secretion of Exosomes and the Localization of beta-Catenin

Autophagy deficiency stabilizes TWIST1 to promote epithelial-mesenchymal transition.

Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins

SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition

Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)

The Homeostasis of p62/SQSTM1 Short Isoform Regulates Selective Autophagy

P62/sqstm1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.

VPS34 Stimulation of P62 Phosphorylation for Cancer Progression

Hepatocytic P62 Suppresses Ductular Reaction and Tumorigenesis in Mouse Livers with Mtorc1 Activation and Defective Autophagy.

P62 Functions As an Oncogene in Colorectal Cancer Through Inhibiting Apoptosis and Promoting Cell Proliferation by Interacting with the Vitamin D Receptor.

P62 Acts As an Oncogene and is Targeted by Mir-124-3p in Glioma